Overview

A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy Participants

Status:
RECRUITING
Trial end date:
2025-09-29
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the effect of capivasertib on the pharmacokinetics (PK) of oral rosuvastatin in healthy participants.
Phase:
PHASE1
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Parexel
Treatments:
capivasertib
Rosuvastatin Calcium